Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Hib Conjugate Vaccine in 2–11 Month Infants
CTR20140068Phase 3Completed
- Sponsor
- Wuhan Institute of Biological Products
- Start
- Mar 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Haemophilus b conjugate vaccine in Haemophilus influenzae type b disease (Hib), sponsored by Wuhan Institute of Biological Products. Started Mar 2014; status: completed.
02
Drugs
Haemophilus b conjugate vaccine
03
Conditions
Haemophilus influenzae type b disease (Hib)
Beyond the preview
Go deeper on CTR20140068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140068.